Novo Nordisk winds down clinical activities in Russia
Russia’s invasion of Ukraine has now also impacted Danish pharmaceutical firm Novo Nordisk, which has chosen not to initiate new trials in addition to halting patient recruitment for existing ones in the country.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
Novo Nordisk’s clinical activities in Russia will taper off due to the invasion of Ukraine, as reported by Danish business daily Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
